2020
DOI: 10.1111/bph.15018
|View full text |Cite
|
Sign up to set email alerts
|

Mitochondrial ion channels in pancreatic β‐cells: Novel pharmacological targets for the treatment of Type 2 diabetes

Abstract: Funding information Nestle ResearchPancreatic beta-cells are central regulators of glucose homeostasis. By tightly coupling nutrient sensing and granule exocytosis, beta-cells adjust the secretion of insulin to the circulating blood glucose levels. Failure of beta-cells to augment insulin secretion in insulin-resistant individuals leads progressively to impaired glucose tolerance, Type 2 diabetes, and diabetes-related diseases. Mitochondria play a crucial role in β-cells during nutrient stimulation, linking th… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
11
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 17 publications
(12 citation statements)
references
References 155 publications
0
11
0
Order By: Relevance
“…pro-inflammatory mediators (e.g., cytokines) [71], proinsulin misfolding [72,73], human islet amyloid polypeptide misfolding [74], as well as endoplasmic reticulum stress [75], which these sequential events initiate apoptosis, increase β-cell workload and stress, culminate in exhaustion, and finally β-cell death [76][77][78][79][80]. Therefore, creating a successful treatment for T2D will need to specifically include targeting insulin resistance, regenerating β-cell mass, and restoring appropriate insulin release by recovery and increase of β-cell function.…”
Section: Discussionmentioning
confidence: 99%
“…pro-inflammatory mediators (e.g., cytokines) [71], proinsulin misfolding [72,73], human islet amyloid polypeptide misfolding [74], as well as endoplasmic reticulum stress [75], which these sequential events initiate apoptosis, increase β-cell workload and stress, culminate in exhaustion, and finally β-cell death [76][77][78][79][80]. Therefore, creating a successful treatment for T2D will need to specifically include targeting insulin resistance, regenerating β-cell mass, and restoring appropriate insulin release by recovery and increase of β-cell function.…”
Section: Discussionmentioning
confidence: 99%
“…VDAC1 plays a central role in many cellular processes ranging from energy metabolism to the triggering of mitochondria-mediated apoptosis [8,9]. For these reasons, VDAC1 is often regarded as a promising target for the treatment of metabolic disorders [10] as well as cancer [11,12] and neurogenerative diseases [13,14] where pro-and anti-apoptotic action are required, respectively. At the molecular level, VDAC1 regulation is characterized by the ability of the channel to switch or "gate" between a high-conducting open state, which is permeable to most ions and metabolites, and multiple low-conducting closed states, which display a reduced ion conductance and are impermeable to large metabolites [6,15].…”
Section: Introductionmentioning
confidence: 99%
“…Mitochondria have a double membrane structure, namely mitochondrial inner membrane (MIM) and mitochondrial outer membrane (MOM), both of which contain selective and nonselective ion channels and transporters [ 6 , 7 ]. The MOM with a simple structure is a permeable membrane for small molecules and ions, while the MIM is highly impermeable and its passive transport mode is usually driven by electrochemistry [ 8 , 9 ]. The recently discovered mitochondrial metal ion channels/transporters are mainly located on these mitochondrial membranes, especially the MIM.…”
Section: Introductionmentioning
confidence: 99%